ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,099Medicare Part D Prescriptions Filled, Including Refills

Rank: 69 out of 1111

$769K Total Retail Price of All Prescriptions

Rank: 81 out of 1111

671 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 671 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

31% of this provider’s 671 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

4% of this provider’s 9,965 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 1,321 667 S3 1 1
LISINOPRIL 537 410 2 2
HYDROCHLOROTHIAZIDE 457 357 3 11
SIMVASTATIN 401 317 4 5
OMEPRAZOLE 391 324 5 4
AMLODIPINE BESYLATE 333 291 6 7
LEVOTHYROXINE SODIUM 320 262 7 3
PREDNISONE 318 244 8 48
METOPROLOL TARTRATE 294 242 9 12
METFORMIN HCL 293 216 10 8
FUROSEMIDE 275 216 11 6
ATENOLOL 261 239 12 22
POTASSIUM CHLORIDE 243 210 13 9
LOVASTATIN 216 196 14 41
PRAVASTATIN SODIUM 204 144 15 17
ZOLPIDEM TARTRATE 195 167 16 16
GABAPENTIN 192 113 17 10
MELOXICAM 191 139 18 18
AMITRIPTYLINE HCL 187 114 R 19 64
FENTANYL 178 95 S2 20 65
GLYBURIDE 169 123 R 21 59
MORPHINE SULFATE ER 158 48 S2 22 74
TRAMADOL HCL 154 77 23 13
NEXIUM 149 115 24 26
NAPROXEN 137 88 25 85
FLUTICASONE PROPIONATE 135 102 26 27
RANITIDINE HCL 133 100 27 29
IBUPROFEN 133 72 27 66
BACLOFEN 129 86 29 119
PAROXETINE HCL 123 103 30 55
LANTUS 116 87 31 46
CLOPIDOGREL 106 81 32 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 105 80 33 23
ALENDRONATE SODIUM 100 89 34 35
LOSARTAN POTASSIUM 94 78 35 34
TAMSULOSIN HCL 88 81 36 28
NIFEDIPINE ER 86 79 37 185
VERAPAMIL ER 83 72 38 100
CARVEDILOL 82 65 39 21
GLIPIZIDE 82 71 39 57
TRAZODONE HCL 80 53 41 32
PLAVIX 79 58 42 49
ISOSORBIDE MONONITRATE ER 79 63 42 73
WARFARIN SODIUM 79 71 42 19
ALLOPURINOL 78 64 45 36
GLIPIZIDE ER 76 63 46 99
CITALOPRAM HBR 75 48 47 14
DONEPEZIL HCL 73 67 48 25
FLUOXETINE HCL 72 30 49 44
INSULIN SYRINGE 70 44 50 167
METOPROLOL SUCCINATE 69 55 51 20
CYCLOBENZAPRINE HCL 68 21 R 52 37
LEVEMIR 65 39 53 132
SPIRONOLACTONE 64 41 54 83
CARISOPRODOL 64 0 R 54 54
PROAIR HFA 63 35 56 38
AZITHROMYCIN 57 42 57 39
DIGOXIN 55 43 58 47
DIOVAN 55 55 58 51
TRIAMTERENE-HCTZ 53 45 60 80
DIOVAN HCT 51 47 61 94
TERAZOSIN HCL 50 45 62 127
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.